Enhancing Oral Absorption of β-Lapachone: Progress Till Date

Area of Science:

• Pharmacology and Drug Delivery
• Cancer Therapeutics
• Nanotechnology

Background:

• β-Lapachone, a naphthoquinone, exhibits significant anticancer properties by inducing selective apoptosis in tumor cells.
• Clinical use of β-lapachone is hindered by poor solubility and limited distribution, restricting its therapeutic potential.
• Effective drug delivery systems are crucial to overcome these limitations and enhance β-lapachone's efficacy.

Purpose of the Study:

• To review and summarize recent formulation strategies aimed at improving β-lapachone's solubility and bioavailability.
• To explore advanced delivery systems for oral, topical, and local administration of β-lapachone.
• To assess the potential of these formulations in enhancing therapeutic outcomes for various pathologies, particularly cancer.

Main Methods:

• Literature review of recent studies on β-lapachone formulations.
• Analysis of strategies including cyclodextrin complexation, micelles, microparticles, and hydrogels.
• Evaluation of formulation effectiveness based on solubility, bioavailability, and targeted delivery data.

Main Results:

• Oral formulations using cyclodextrins, micelles, and microparticles have successfully improved β-lapachone solubility and oral bioavailability.
• Temperature-sensitive hydrogels enable high drug concentrations for topical and local applications.
• Subcutaneous polymeric micelles demonstrate prolonged circulation and enhanced tumor tissue accumulation.

Conclusions:

• Formulation strategies significantly enhance β-lapachone's therapeutic applicability by addressing its solubility and distribution challenges.
• Advanced delivery systems offer promising avenues for improving β-lapachone's efficacy in cancer treatment and other pathologies.
• Further development of these formulations is essential for realizing the full clinical potential of β-lapachone.